New England J Med 381(9):84151 Mansoor H, L BA, Morten D, Kathleen D, G EF, R FD et al (2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
The clinical differences are more subtle than the price gap suggests
Pros: Helps regulate appetite Lowers blood sugar Can result in significant weight loss Cons: Can lead to muscle loss if protein isnt prioritized Often regain weight after stopping Can cause digestive issues, nausea, or vomiting Long-term effects are still being studied Often expensive and not always covered by insurance Can Foods Naturally Promote GLP-1
Atherosclerotic plaque fissuration and clinical outcomes in Pre-diabetics vs
34 In human research, administration of prebiotic fiber has been associated with a significant decrease in hunger, significantly greater satiation after meals and increased plasma GLP-1 levels
While the Medicare GLP-1 Bridge Program has expanded access to certain obesity medications for eligible beneficiaries, not everyone with Medicare will qualify
